Immunochemotherapy Response May Allow Less Invasive Surgery for Advanced Head and Neck Cancer
Source Summary
A study published in Clinical Cancer Research found that patients with locally advanced head and neck squamous cell carcinoma whose tumors responded to neoadjuvant immunochemotherapy and underwent less extensive surgery achieved high disease-free survival and organ preservation rates. The research was led by Dr. Kunyu Yang, director of Union Hospital Cancer Center at Tongji Medical College and Huazhong University of Science and Technology in China.
Why it matters
The findings suggest that tumor response to immunochemotherapy could enable some head and neck cancer patients to avoid radical surgery while maintaining high survival rates and preserving organ function.
